RUNX1::MECOM rearrangement in myeloid neoplasm post cytotoxic therapy following sarcoma treatment: a case presentation and review of the literature
Objectives Myeloid neoplasms occurring after cytotoxic therapy (MN-pCT), previously termed therapy-related myelodysplastic neoplasia (MDS) or therapy-related acute myelogenous leukemia (AML), pose significant treatment challenges due to high resistance, poor chemotherapy tolerance, and relapse.Metho...
Saved in:
| Main Authors: | Miriam Sandnes, Øystein Sefland, Irini Ktoridou-Valen, Rakel Brendsdal Forthun, Hilde Kollsete Gjelberg, Lars Henrik Dahl Hamnvik, Håkon Reikvam, Tor Henrik Andersson Tvedt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2483094 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
by: Soumya Mikkilineni, et al.
Published: (2025-04-01) -
Prognosis of RUNX1-RUNX1T1 Rearrangement in Newly Diagnosed Acute Myeloid Leukemia Patients
by: Halima Babar, et al.
Published: (2023-10-01) -
Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1‐RUNX1T1
by: Yibo Wu, et al.
Published: (2025-01-01) -
Family platelet disorder with propensity to acute myeloid leukemia: new family with RUNX1 mutation
by: V. O. Bobrynina, et al.
Published: (2014-07-01) -
Systematic pan-cancer analysis of the prognostic value of MECOM in human cancer
by: Yingqiang Lu, et al.
Published: (2024-11-01)